2 new MIDOS signals
EXTREME
VIX 22.2 (88% ptl) · Position: 25%
GSK
GSK PLC-ADR
Health Care·Pharmaceuticals·BRITAIN
$51.25
MCap $102.7B
as of 2026-06-09
Total
C
1w
Fund
D
1w
Quant
C
1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.35
Sentiment 22.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$51.25
Adaptive Mean
$50.89
+0.36 vs mean
Adaptive σ
0.51
MIDOS BB
$49.86 – $51.91
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.07
ROE
36.4%
Z +0.86
Rev Gr
1.5%
Z -0.29
EPS Gr
Z
OPM Gr
1.9%
Z -0.34
FCF Yld
7.8%
Z +0.53
EPS Surp
-46.2%
Z -0.53
EPS 3mo Δ
0.4%
Z +0.18
Fwd P/E
9.80
Z
PEGY
0.03
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-8.90
Q6M
1.95
Q12M
3.62
MA 30/100
0.947
Bearish (MA30 < MA100)
α (Jensen)
-0.4293
β (12M)
0.38
σ (12M)
0.269
Divergence — Fundamentals vs Momentum
Z Percentile
63%
Q Percentile
73%
Divergence
-10.2
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-0.1
RS Pctl
52%
RS Decile
D6
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.